These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16241945

  • 1. Old and new risk factors for upper extremity deep venous thrombosis.
    Blom JW, Doggen CJ, Osanto S, Rosendaal FR.
    J Thromb Haemost; 2005 Nov; 3(11):2471-8. PubMed ID: 16241945
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.
    Van Rooden CJ, Rosendaal FR, Meinders AE, Van Oostayen JA, Van Der Meer FJ, Huisman MV.
    Haematologica; 2004 Feb; 89(2):201-6. PubMed ID: 15003896
    [Abstract] [Full Text] [Related]

  • 4. Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    Vayá A, Todolí J, Ricart J, Estellés T, Mira Y, Villa P, Calabuig JR, Aznar J.
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):72-4. PubMed ID: 11190909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.
    N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?
    Kreidy R, Irani-Hakime N.
    Vasc Health Risk Manag; 2009 Sep 09; 5():627-33. PubMed ID: 19688103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.
    Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM, Lowe GD.
    Br J Haematol; 2002 Mar 09; 116(4):851-4. PubMed ID: 11886391
    [Abstract] [Full Text] [Related]

  • 18. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
    Pomp ER, le Cessie S, Rosendaal FR, Doggen CJ.
    Br J Haematol; 2007 Oct 09; 139(2):289-96. PubMed ID: 17897305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.